Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located in the heart of Cambridge was recently launched by an exceptional group of academic leaders and successful bioentrepreneurs converging stem cell biology, immunology, regenerative medicine, and gene editing into the next-generation of stem cell-derived medicines.
Location: United States, Massachusetts, Cambridge
Member count: 11-50
Total raised: $87M
Founded date: 2020
Investors 1
| Date | Name | Website |
| 04.11.2021 | Syncona Pa... | synconaltd... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 03.11.2021 | Series A | $87M | - | globenewsw... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 03.11.2021 | Clade Ther... | Clade’s iPSC immune cloaking a... | - | - | marketscre... |
| 03.11.2021 | Clade Ther... | CAMBRIDGE, Mass., Nov. 03, 202... | - | - | globenewsw... |